Inpiduals promoting these unapproved and fraudulent products must take immediate action to correct or remove these claims or face potential FDA action.
It is important to note that according to the Centers for Disease Control and Prevention (CDC), Ebola does not pose a significant risk to the U.S. public. Unfortunately, during outbreak situations, fraudulent products that claim to prevent, treat, or cure a disease all too often appear on the market. The FDA monitors for these fraudulent products and false claims and takes appropriate action to protect consumers.
Ebola is the cause of a viral hemorrhagic fever disease. Symptoms include fever, headache, joint and muscle aches, weakness, diarrhea, vomiting, stomach pain, lack of appetite, and abnormal bleeding. Symptoms of the virus can appear anywhere from two to 21 days after exposure, but is most commonly seen on days eight to 10.
In the United States, Ebola is not a water-borne or food-borne illness and is not transmitted through the air. Ebola is spread through direct contact with the body fluids of an infected person, or with objects like needles that have been contaminated with the virus. People who do not show symptoms are not contagious.
Consumers who have seen these fraudulent products or false claims are encouraged to report them to the FDA.
- 克里希纳·埃拉|参考封面秀 | 印度疫苗研发先锋
- 红星深度丨奥密克戎传染性有多强?美专家:“非常高”,或为埃博拉的5倍
- 埃塞俄比亚|非洲确诊已超千万
- 咖啡加洋葱可治疗埃博拉 这是真的么
- “毒油条”案尘埃落定 法官摊点告诫商贩诚信经营
- 埃斯特·朱|医护人员不断流失!美国新冠确诊病例激增 医疗系统遭重创
- 埃塞科学家发明恰特草酒
- 埃及科学家研究发现绿茶可提高抗生素药效
- 埃博拉:世上最高级别的病毒之一,每隔几年爆发一次,有多可怕?
- 梅里埃推出新的TEMPO解决方案用于快速计数酵母菌和霉菌以提高食